David Evans (geneticist)

Last updated

David Evans
Nationality Australian
Education University of Queensland
Known for Mendelian randomization
Complex trait genetics
Scientific career
Fields Statistical genetics
Institutions University of Bristol
University of Queensland

David M. Evans is Professor of Statistical Genetics and Head of Genomic Medicine at the Diamantina Institute at the University of Queensland. He received his Ph.D. from the University of Queensland in 2003, after which he completed a four-year postdoc at the University of Oxford's Wellcome Trust Centre for Human Genetics. During his postdoc, he conducted research for the International HapMap Project and the Wellcome Trust Case Control Consortium. In 2007, he became a senior lecturer at the University of Bristol, where he conducted research on genome-wide association studies based on the Avon Longitudinal Study of Parents and Children. He became a professor at the University of Queensland in 2013. [1] He is known for researching the genetics of complex traits in humans, such as osteoporosis, [2] [3] asthma, [4] [5] and binge eating. [6] He was an ISI Highly Cited Researcher in 2015 and 2016. [7]

Related Research Articles

Medical Research Council (United Kingdom) State institution responsible for co-ordinating and funding medical research in the United Kingdom

The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.

Ronald Mark Evans is an American Biologist, Professor and Head of the Salk’s Gene Expression Laboratory, and the March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute for Biological Studies in La Jolla, California and a Howard Hughes Medical Institute Investigator. Dr. Ronald M. Evans is known for his original discoveries of nuclear hormone receptors (NR), a special class of transcriptional factor, and the elucidation of their universal mechanism of action, a process that governs how lipophilic hormones and drugs regulate virtually every developmental and metabolic pathway in animals and humans. Nowadays, NRs are among the most widely investigated group of pharmaceutical targets in the world, already yielding benefits in drug discovery for cancer, muscular dystrophies, osteoporosis, type II diabetes, obesity, and cardiovascular diseases. His current research focuses on the function of nuclear hormone signaling and their function in metabolism and cancer.

Sir Walter Fred Bodmer is a German-born British human geneticist.

Wellcome Sanger Institute British genomics research institute

The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.

Sir Peter James Donnelly is an Australian mathematician and Professor of Statistical Science at the University of Oxford, and the CEO of Genomics PLC. He is a specialist in applied probability and has made contributions to coalescent theory. His research group at Oxford has an international reputation for the development of statistical methodology to analyze genetic data.

John Andrew Todd FMedSci FRS is Professor of Precision Medicine at the University of Oxford, director of the Wellcome Center for Human Genetics and the JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, in addition to Jeffrey Cheah Fellow in Medicine at Brasenose College. He works in collaboration with David Clayton and Linda Wicker to examine the molecular basis of type 1 diabetes.

Sir Peter Stanley Harper is a British physician and academic who is University Research Professor (Emeritus) in Human Genetics at Cardiff University. His work has focused on researching neurogenetics and has resulted in discoveries concerning muscular dystrophies and Huntington's disease. He was knighted in 2004 for services to medicine.

Wellcome Centre for Human Genetics

The Wellcome Centre for Human Genetics is a human genetics research centre of the Nuffield Department of Medicine in the Medical Sciences Division, University of Oxford, funded by the Wellcome Trust among others.

Stephen ORahilly

Sir Stephen Patrick O'Rahilly is an Irish-British physician and scientist known for his research into the molecular pathogenesis of human obesity, insulin resistance and related metabolic and endocrine disorders.

Karen Penelope Steel FRS FMedSci is a British scientist who studies the genetics of deafness, using the mouse as a model to identify the genes involved and to understand the molecular, cellular and physiological mechanisms involved. She is Professor of Sensory Function at the Wolfson Centre for Age-Related Diseases, King's College London. Previously she was Principal Investigator of the Genetics of Deafness research programme at the Wellcome Trust Sanger Institute.

The History of Modern Biomedicine Research Group (HoMBRG) is an academic organisation specialising in recording and publishing the oral history of twentieth and twenty-first century biomedicine. It was established in 1990 as the Wellcome Trust's History of Twentieth Century Medicine Group, and reconstituted in October 2010 as part of the School of History at Queen Mary University of London.

Eleftheria Zeggini is a director of the institute of translational genomics in Helmholtz Zentrum München and a professor at the Technical University of Munich (TUM). Previously she served as a research group leader at the Wellcome Trust Sanger Institute from 2008 to 2018 and an honorary professor in the department of health sciences at the University of Leicester in the UK.

Sir Douglass Matthew Turnbull is Professor of Neurology at Newcastle University, an Honorary Consultant Neurologist at Newcastle upon Tyne Hospitals NHS Foundation Trust and a director of the Wellcome Trust Centre for Mitochondrial Research.

Sadaf Farooqi British consultant physician

(Ismaa) Sadaf Farooqi FMedSci is a Wellcome Trust Senior Research fellow in Clinical Science, professor of Metabolism and Medicine at the University of Cambridge and a consultant physician at Addenbrooke's Hospital in Cambridge, UK.

Anurag Agrawal is an Indian pulmonologist, medical researcher and the director of the Institute of Genomics and Integrative Biology, a CSIR institution. Known for his studies on lung diseases, Agrawal is a senior fellow of the DBT-Wellcome Trust. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2014. He is also a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology which he received in 2015.

Jonathan Flint is a British behavior geneticist and Professor in Residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA. He is also a senior scientist in the Center for Neurobehavioral Genetics at UCLA's Semel Institute for Neuroscience and Human Behavior.

The Department of Genetics is a department of the University of Cambridge that conducts research and teaching in genetics.

The Wellcome Trust Case Control Consortium is a collaboration between fifty research groups in the United Kingdom in the field of human genetics. Established in 2005, the WTCCC aims to conduct genome-wide association studies (GWASs) to shed light on the genetic architecture of common human diseases. The founding chairman of the consortium was University of Oxford statistician Peter Donnelly. The consortium was funded by £9 million from the Wellcome Trust. According to the consortium's website, it has identified "approximately 90" new susceptibility loci for common human diseases.

Charles Rotimi Nigerian geneticist

Charles Nohuoma Rotimi is the Director of the Trans-National Institutes of Health (NIH) center for research in genomics and global health. He works to ensure that population genetics include genomes from African populations and founded the African Society of Human Genetics in 2003. Rotimi was instrumental in the launch of the Human Heredity and Health in Africa (H3Africa) with the NIH and the Wellcome Trust. He was elected to the National Academy of Medicine in 2018.

Christine Patch Nurse and genetic counsellor

Christine Patch is a nurse and genetic counsellor. She is a Principal Staff Scientist in Genomic Counselling in the Society and Ethics Research group, part of Wellcome Connecting Science, based on the Wellcome Genome Campus. She is also the Clinical Lead for Genetic Counselling at Genomics England, and a former President of the European Society of Human Genetics.

References

  1. "David Evans". Mendelian Randomization Conference. Retrieved 6 November 2018.
  2. Ross, John (5 September 2017). "Genetic research ushers drugs, screening for osteoporosis". The Australian.
  3. "New genetic clue in osteoporosis found". SBS News. 5 September 2017. Retrieved 6 November 2018.
  4. Corderoy, Amy (2 July 2014). "Obesity causing asthma - study". Sydney Morning-Herald. Retrieved 6 November 2018.
  5. Hall, Ashley (2 July 2014). "Scientists discover link between rates of obesity and asthma". ABC News. Retrieved 6 November 2018.
  6. "Have they just found the key to obesity?". NewsComAu. 22 July 2015. Retrieved 6 November 2018.
  7. "Profile: Professor David Evans" (PDF). UQ Medicine. University of Queensland. Winter 2017. p. 5. Retrieved 6 November 2018.